Correlation
The correlation between LYFIX and IBB is 0.57, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
LYFIX vs. IBB
Compare and contrast key facts about AlphaCentric LifeSci Healthcare Fund (LYFIX) and iShares Nasdaq Biotechnology ETF (IBB).
LYFIX is managed by AlphaCentric Funds. It was launched on Nov 28, 2019. IBB is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology Index. It was launched on Feb 5, 2001.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LYFIX or IBB.
Performance
LYFIX vs. IBB - Performance Comparison
Loading data...
Key characteristics
LYFIX:
0.13
IBB:
-0.37
LYFIX:
0.22
IBB:
-0.40
LYFIX:
1.03
IBB:
0.95
LYFIX:
0.07
IBB:
-0.25
LYFIX:
0.18
IBB:
-0.93
LYFIX:
6.87%
IBB:
9.65%
LYFIX:
17.39%
IBB:
22.86%
LYFIX:
-35.34%
IBB:
-62.85%
LYFIX:
-15.38%
IBB:
-30.18%
Returns By Period
In the year-to-date period, LYFIX achieves a -4.68% return, which is significantly higher than IBB's -7.85% return.
LYFIX
-4.68%
-4.22%
-11.12%
2.18%
6.10%
6.31%
N/A
IBB
-7.85%
-3.84%
-13.89%
-8.47%
1.72%
-1.74%
0.28%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LYFIX vs. IBB - Expense Ratio Comparison
LYFIX has a 1.40% expense ratio, which is higher than IBB's 0.47% expense ratio.
Risk-Adjusted Performance
LYFIX vs. IBB — Risk-Adjusted Performance Rank
LYFIX
IBB
LYFIX vs. IBB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AlphaCentric LifeSci Healthcare Fund (LYFIX) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
LYFIX vs. IBB - Dividend Comparison
LYFIX's dividend yield for the trailing twelve months is around 2.34%, more than IBB's 0.31% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LYFIX AlphaCentric LifeSci Healthcare Fund | 2.34% | 2.23% | 2.63% | 4.43% | 12.87% | 2.29% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IBB iShares Nasdaq Biotechnology ETF | 0.31% | 0.29% | 0.26% | 0.31% | 0.21% | 0.20% | 0.17% | 0.19% | 0.30% | 0.19% | 0.03% | 0.15% |
Drawdowns
LYFIX vs. IBB - Drawdown Comparison
The maximum LYFIX drawdown since its inception was -35.34%, smaller than the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for LYFIX and IBB.
Loading data...
Volatility
LYFIX vs. IBB - Volatility Comparison
The current volatility for AlphaCentric LifeSci Healthcare Fund (LYFIX) is 6.65%, while iShares Nasdaq Biotechnology ETF (IBB) has a volatility of 10.26%. This indicates that LYFIX experiences smaller price fluctuations and is considered to be less risky than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...